According to the latest report by IMARC Group, titled “Cannabis Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global cannabis testing market size reached US$ 1,269 Million in 2022. Cannabis testing refers to the process of analyzing cannabis products to determine their chemical composition, potency, and purity. It includes various tests for cannabinoids, heavy metals, residual solvents, pesticides, terpenes, and microbial contaminants. It is widely used for breeding and cultivation, medical research, consumer safety, product development, and quality control. Cannabis testing improves product transparency, ensures consistency, increases trust, and protects users from harmful substances and toxic chemicals. It is also a highly reliable and efficient process that helps manufacturers and researchers in developing advanced cannabis strains with improved flavor profiles and therapeutic benefits.
Cannabis Testing Market Trends:
The growing legalization of cannabis for recreational purposes across the globe is one of the primary factors driving the market growth. Cannabis testing plays a critical role in the manufacturing process to ensure the safety and purity of products, meet quality standards, and protect consumers from harmful chemicals, diseases, and various toxic metals, such as lead and cadmium. In addition to this, the rising number numbers of cannabis products, such as oils, edibles, capsules, concentrates, tinctures, topicals, and vape cartridges, is acting as another growth-inducing factor. Furthermore, the increasing adoption of cannabis in medical research to treat various conditions, such as chronic pain, anxiety, and epilepsy, is propelling the market growth. Additionally, the introduction of portable testing devices that use spectroscopy and chromatography to provide faster and more accurate results in real-time is positively influencing the market growth. Apart from this, the integration of next-generation sequencing (NGS) in testing methods to identify genetic markers and optimize breeding programs for developing desirable cannabis traits and strains is creating a positive outlook for the market. Other factors, including rising consumer awareness regarding the importance of the safety and quality of cannabis products, increasing investment in the research and development (R&D) of innovative testing devices, and the incorporation of advanced technologies, such as blockchain and artificial intelligence (AI), are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 2,619 Million by 2028, exhibiting a CAGR of 13.00% during 2023-2028.
- On the basis of the product type, the market has been divided into instruments (chromatography instruments and spectroscopy instruments), consumables, and software. Among these, instruments (chromatography instruments and spectroscopy instruments) represented the largest segment.
- Based on the test type, the market has been classified into heavy metal testing, microbial analysis, potency testing, residual screening, and others. Among these, potency testing accounted for the largest market share.
- On the basis of end user, the market has been divided into cannabis cultivators/growers, cannabis drug manufacturers, and others. Among these, cannabis cultivators/growers accounted for the largest market share.
- On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa. Among these, North America holds the largest market.
- The competitive landscape of the industry has also been examined, with some of the key players being AB Sciex Pte. Ltd, Accelerated Technology Laboratories Inc., Agilent Technologies Inc., Digipath Inc., Merck KGaA (Sigma Aldrich), PerkinElmer Inc., Pharmlabs LLC, Sartorius AG, SC Laboratories Inc., Shimadzu Corporation, Steep Hill Inc., Thermo Fisher Scientific Inc., Water Corporation, etc.
|Base Year of the Analysis
|Product Types Covered
- Instruments:Chromatography Instruments,Spectroscopy Instruments
|Test Types Covered
||Heavy Metal Testing, Microbial Analysis, Potency Testing, Residual Screening, Others
|End Users Covered
||Cannabis Cultivators/Growers, Cannabis Drug Manufacturers, Others
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||AB Sciex Pte. Ltd, Accelerated Technology Laboratories Inc., Agilent Technologies Inc., Digipath Inc., Merck KGaA (Sigma Aldrich), PerkinElmer Inc., Pharmlabs LLC, Sartorius AG, SC Laboratories Inc., Shimadzu Corporation, Steep Hill Inc., Thermo Fisher Scientific Inc., Water Corporation, etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800